Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Suven Granted Two Patents for New Neuro Drug Candidates

publication date: May 21, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Suven Life Sciences Ltd, headquartered in Hyderabad, India, was granted patents In China and South Africa for two new chemical entities (NCEs) that treat disorders associated with neuro-degenerative diseases. Both NCEs belong to the class of selective 5-HT compounds. They are being developed as therapeutic agents for the treatment of cognitive impairment. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...